Table 3.

Risk grouping following discharge from allogeneic hematopoietic cell transplantation in childhood or adolescence.

Risk assessment at time of discharge, day 100, day 180
Low risk	Int risk	High risk
No GvHD	No or controlled GvHD	Active/uncontrolled GvHD
No IST	Low IST	Multimodal IST
No infections	Recurrent infections	Viral reactivations
CD4 > 200	CD4 100-200	CD4 <100
N > 0.5 × 109/l	N ≤ 0.5 × 109/l	N ≤ 0.5 × 109/l

GvHD, graft vs. host disease; IST, immune suppressive therapy; CD4, CD positive T-lymphocytes; N, neutrophil count.